European Medicines Agency (EMA) | What's new 한국어 팔로우 고아 지정: 2-[6-(6,7-디메톡시퀴놀린-3-일)피리딘-3-일]-N-[3-(1,1,1-트리플루오로-2-메틸프로판-2-일)-1,2-옥사졸-5-일]아세트아미드 (제텔레티닙) 수질 갑상선암 치료, 2021년 2월 19일 철회 Orphan designation: 2-[6-(6,7-Dimethoxyquinolin-3-yl)pyridin-3-yl]-N-[3-(1,1,1-trifluoro-2-methylpropan-2-yl)-1,2-oxazol-5-yl]acetamide (zeteletinib) Treatment of medullary thyroid carcinoma, 19/02/2021 Withdrawn ema.europa.eu
